Previous 10 | Next 10 |
Gainers: Clarus Therapeutics Holdings (CRXT) +87%. Winc (WBEV) +27%. AlloVir (ALVR) +26%. NexImmune (NEXI) +24%. Charah Solutions (CHRA) +22%. Target Hospitality (TH) +20%. Phio Pharmaceuticals (PHIO) +20%. Healthcare Services Group (HCSG) +19%. CEL-SCI (CVM) +18%. Biophytis (BPTS) +17%. Lose...
RenovoRx press release (NASDAQ:RNXT): FY Net Loss of $6.3M Cash and cash equivalents as of December 31, 2021, were $15.2 million Shares +1.67% PM. For further details see: RenovoRx reports FY results
RenovoRx, Inc. (“RenovoRx” or the “Company”) (Nasdaq: RNXT), a biopharmaceutical company and innovator in targeted cancer therapy, today is reporting its financial results for the year ended December 31, 2021. “2021 was a transformative year for Re...
RenovoRx, Inc. (“RenovoRx” or the “Company”) (Nasdaq: RNXT), a biopharmaceutical company and innovator in targeted cancer therapy, today announced its leadership’s participation in two upcoming Investor Conferences this month. ROTH Capital Partne...
Study Evaluating Company’s Novel Therapy Platform in Pancreatic Cancer RenovoRx, Inc. (“RenovoRx” or the “Company”) (Nasdaq: RNXT), a biopharmaceutical company and innovator in targeted cancer therapy, today announced enrollment of its firs...
RenovoRx, Inc. (“RenovoRx” or the “Company”) (Nasdaq: RNXT), a biopharmaceutical company and innovator in targeted cancer therapy, will host the “Delivering Therapy Where it Matters” fireside chat with CEO, Shaun Bagai, on Wednesday, February 23...
Presentation Featured RenovoTAMP ™ (RenovoRx Trans-Arterial Micro-Perfusion) and the Phase 3 TIGeR-PaC Clinical Trial RenovoRx, Inc. (“RenovoRx” or the “Company”) (Nasdaq: RNXT), a biopharmaceutical company and innovator in targ...
RenovoRx, Inc. (NASDAQ: RNXT), a biopharmaceutical company and innovator in targeted cancer therapy, today announced that Shaun Bagai, Chief Executive Officer, will participate in the H.C. Wainwright Bioconnect Virtual Conference on behalf of RenovoRx. The conference will be held Januar...
Gainers: Cumberland Pharmaceuticals (NASDAQ:CPIX) +134%. GBS (NASDAQ:GBS) +43%. ImmunoGen (NASDAQ:IMGN) +31%. RenovoRx (NASDAQ:RNXT) +30%. Adagio (NASDAQ:ADGI) +25%. Losers: Triumph Group (NYSE:TGI) -14%. Recruiter (NASDAQ:RCRT) -12%. Hexcel (NYSE:HXL) -10%. United Airlines (NASDAQ:UAL) -10%....
InvestorPlace - Stock Market News, Stock Advice & Trading Tips Short squeeze stocks are a subject frequently mentioned on social media, and rightfully so. A short squeeze occurs when a heavily shorted stock moves higher. As the stock moves higher, traders who shorted the company must b...
News, Short Squeeze, Breakout and More Instantly...
LOS ALTOS, Calif., July 08, 2024 (GLOBE NEWSWIRE) -- RenovoRx, Inc . (“RenovoRx” or the “Company”) (Nasdaq: RNXT) , a clinical-stage biopharmaceutical company developing novel precision oncology therapies based on a local drug-delivery platform, today annou...
LOS ALTOS, Calif., June 26, 2024 (GLOBE NEWSWIRE) -- RenovoRx, Inc . (“RenovoRx” or the “Company”) (Nasdaq: RNXT) , a clinical-stage biopharmaceutical company developing novel precision oncology therapies based on a local drug-delivery platform, announced t...
LOS ALTOS, Calif., June 10, 2024 (GLOBE NEWSWIRE) -- RenovoRx, Inc . (“RenovoRx” or the “Company”) (Nasdaq: RNXT) , a clinical-stage biopharmaceutical company developing novel precision oncology therapies based on a local drug-delivery platform, announced t...